Squarepoint’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.47M | Sell |
55,355
-383,576
| -87% | -$10.2M | ﹤0.01% | 1310 |
|
2025
Q1 | $10.6M | Buy |
438,931
+171,626
| +64% | +$4.14M | 0.01% | 529 |
|
2024
Q4 | $10.8M | Buy |
267,305
+233,051
| +680% | +$9.38M | 0.01% | 520 |
|
2024
Q3 | $2.17M | Sell |
34,254
-107,566
| -76% | -$6.81M | ﹤0.01% | 1099 |
|
2024
Q2 | $7.52M | Buy |
+141,820
| New | +$7.52M | 0.01% | 550 |
|
2024
Q1 | – | Sell |
-50,603
| Closed | -$942K | – | 2971 |
|
2023
Q4 | $942K | Buy |
50,603
+23,673
| +88% | +$441K | ﹤0.01% | 1374 |
|
2023
Q3 | $298K | Buy |
+26,930
| New | +$298K | ﹤0.01% | 1933 |
|
2023
Q2 | – | Sell |
-26,063
| Closed | -$434K | – | 2868 |
|
2023
Q1 | $434K | Buy |
+26,063
| New | +$434K | ﹤0.01% | 1533 |
|
2022
Q4 | – | Sell |
-14,382
| Closed | -$39K | – | 2646 |
|
2022
Q3 | $39K | Sell |
14,382
-381
| -3% | -$1.03K | ﹤0.01% | 1971 |
|
2022
Q2 | $43K | Sell |
14,763
-3,077
| -17% | -$8.96K | ﹤0.01% | 1972 |
|
2022
Q1 | $54K | Sell |
17,840
-50,279
| -74% | -$152K | ﹤0.01% | 2101 |
|
2021
Q4 | $313K | Buy |
68,119
+37,704
| +124% | +$173K | ﹤0.01% | 1844 |
|
2021
Q3 | $191K | Sell |
30,415
-68,751
| -69% | -$432K | ﹤0.01% | 1848 |
|
2021
Q2 | $594K | Sell |
99,166
-7,089
| -7% | -$42.5K | ﹤0.01% | 1508 |
|
2021
Q1 | $672K | Buy |
106,255
+61,907
| +140% | +$392K | ﹤0.01% | 1335 |
|
2020
Q4 | $250K | Sell |
44,348
-55,336
| -56% | -$312K | ﹤0.01% | 1996 |
|
2020
Q3 | $580K | Buy |
+99,684
| New | +$580K | 0.01% | 1241 |
|
2020
Q1 | – | Sell |
-110,347
| Closed | -$885K | – | 2485 |
|
2019
Q4 | $885K | Buy |
110,347
+29,868
| +37% | +$240K | 0.01% | 1388 |
|
2019
Q3 | $554K | Sell |
80,479
-55,239
| -41% | -$380K | ﹤0.01% | 1513 |
|
2019
Q2 | $1.13M | Buy |
135,718
+85,118
| +168% | +$706K | 0.01% | 1177 |
|
2019
Q1 | $503K | Sell |
50,600
-25,343
| -33% | -$252K | 0.01% | 1460 |
|
2018
Q4 | $581K | Buy |
+75,943
| New | +$581K | 0.01% | 1157 |
|